We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Exposure in utero to SGAs not linked to adverse neurobehavioral outcomes.
- Abstract
Prenatal exposure to second‐generation antipsychotics (SGAs) did not increase risk of adverse childhood developmental or behavioral outcomes compared with antipsychotic‐unexposed children, a study examining preschool‐aged children has found. This was one of the largest studies to date that examined neurobehavioral outcomes in children exposed prenatally to SGAs, the investigators reported. Study results were published online March 13, 2024, in the Journal of Clinical Psychiatry.
- Subjects
PRENATAL exposure delayed effects; NEURAL development; ANTIPSYCHOTIC agents; CHILD development; DRUG efficacy; CHILD behavior; PREGNANCY
- Publication
Brown University Psychopharmacology Update, 2024, Vol 35, Issue 7, p1
- ISSN
1068-5308
- Publication type
Article
- DOI
10.1002/pu.31176